Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Merck set to remove cancer-causing chemical from top diabetes drugs Ruchika Sharma18 Jan 2023 1:15 PM ISTNew Jersey: Merck & Co has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believe it can...
Merck VS Mylan Pharma: US Court of Appeals for the Federal Circuit rules in favor of Merck in Sitagliptin Dihydrogen Phosphate patent lawsuit Ruchika Sharma2 Oct 2022 5:00 PM ISTThe ruling from the U.S. Court of Appeals provides JANUVIA, JANUMET and JANUMET XR patent protection through May 2027, which includes six (6) months...
USFDA says possible carcinogens found in Merck's Sitagliptin drugs Januvia, Janumet Roshni Dhar13 Aug 2022 5:39 PM ISTThe U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and Janumet, were...
Health Bulletin 12/August/2022 Roshni Dhar12 Aug 2022 5:33 PM ISTHere are the Top Health stories for the day:Omicron is not mild for the frail, 32 deaths in Delhi in 10 daysThere have been 32 deaths in the past 10...
Possible carcinogens found in Merck's Sitagliptin drugs Januvia, Janumet: USFDA Ruchika Sharma10 Aug 2022 5:08 PM ISTNew Delhi: The U.S. Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drugs Januvia and...
Zydus Cadila arm gets USFDA nod for Sitagliptin base tablets Ruchika Sharma6 Sept 2021 11:00 AM ISTAhmedabad: Drugmaker, Zydus Cadila, today announced that the company's subsidiary has received tentative approval from the United States Food and...
Patent Infringement: MSD sues firm in Delhi HC over diabetes drug Sitagliptin Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: In a major victory for Merck Sharp and Dohme (MSD) Corp, the Delhi High Court has restrained Solitaire Pharmacia Private from infringing...
Himachal drugmaker agrees to destroy infringed stock of Merck Diabetes Drug Sitagliptin Medical Dialogues Team7 April 2021 6:42 PM ISTNew Delhi: In a relief to Merck, Hariom Pharmachem has agreed to destroy the stock of infringed products of Merck's popular diabetes drug Sitagliptin,...
Merck goes against Dr Reddys alleging patent infringement of diabetes drug Januvia, Janumet Farhat Nasim28 Jun 2020 10:45 AM ISTMerck in its petition filed on June 23, said Dr Reddys had submitted ANDAs (abbreviated new drug application) to the US FDA seeking approval from the...
